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Abstract
Arthrogryposis is a group of phenotypically and genetically hetero-
geneous disorders characterized by congenital contractures of two
or more parts of the body; the pathogenesis and the causative
genes of arthrogryposis remain undetermined. We examined a
four-generation arthrogryposis pedigree characterized by campto-
dactyly, limited forearm supination, and loss of myofibers in the
forearms and hands. By using whole-exome sequencing, we con-
firmed MET p.Y1234C mutation to be responsible for arthrogryposis
in this pedigree. MET p.Y1234C mutation caused the failure of acti-
vation of MET tyrosine kinase. A Met p.Y1232C mutant mouse
model was established. The phenotypes of homozygous mice
included embryonic lethality and complete loss of muscles that
originated from migratory precursors. Heterozygous mice were
born alive and showed reduction of the number of myofibers in
both appendicular and axial muscles. Defective migration of
muscle progenitor cells and impaired proliferation of secondary
myoblasts were proven to be responsible for the skeletal muscle
dysplasia of mutant mice. Overall, our study shows MET to be a
causative gene of arthrogryposis and MET mutation could cause
skeletal muscle dysplasia in human beings.
Keywords arthrogryposis; MET; muscle development; muscular dysplasia;
whole-exome sequence
Subject Categories Genetics, Gene Therapy & Genetic Disease; Muscu-
loskeletal System
DOI 10.15252/emmm.201809709 | Received 21 August 2018 | Revised 28
January 2019 | Accepted 29 January 2019 | Published online 18 February 2018
EMBO Mol Med (2019) 11: e9709
Introduction
Arthrogryposis is a group of disorders characterized by congenital
joint contractures that mainly involve two or more areas of the body
(Bamshad et al, 2009; Bayram et al, 2016) and affects approxi-
mately 1 in 3,000 newborns (Bayram et al, 2016). Structural and
functional disorders of skeletal muscles are the most common
reason for arthrogryposis (Toydemir et al, 2006). Arthrogryposis is
a group of disorders with high clinical and genetic heterogeneity.
Variants in more than 220 genes have been found to be associated
with arthrogryposis (Narkis et al, 2007; Drury et al, 2014; Hunter
et al, 2015; Bayram et al, 2016). However, the molecular etiology
still remains unclear in a large number of cases of arthrogryposis.
Further studies to identify causative genes and pathogenic mecha-
nisms are needed.
MET belongs to the receptor tyrosine kinase family, and it is
encoded by the MET proto-oncogene, receptor tyrosine kinase
(MET, MIM:164860) gene. The biological effects exerted by MET are
triggered by the stimulation of its only ligand, hepatocyte growth
factor (HGF; Trusolino et al, 2010). Upon ligand binding, MET is
autophosphorylated on tyrosine (Y)-1234/1235 in the activation
loop of the MET catalytic domain. Y-1234/1235 phosphorylation is
required for the activation of MET kinase and subsequent phospho-
rylation of other tyrosine sites of MET, including Y-1003 in the
juxtamembrane domain, and Y-1349 and Y-1356 in the carboxyl
terminus (Sangwan et al, 2008). Phosphorylated Y-1349 and Y-1356
1 Department of Orthopaedic Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
2 Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
3 Guangdong Province Center for Peripheral Nerve Tissue Engineering and Technology Research, Guangzhou, Guangdong, China
4 Guangdong Province Engineering Laboratory for Soft Tissue Biofabrication, Guangzhou, Guangdong, China
5 Research Centre for Translational Medicine, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
6 Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
7 Department of Spine Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
8 Department of Laboratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
9 Department of Orthopaedic Surgery, Washington University, St. Louis, MO, USA
10 Department of Neurology, Washington University, St. Louis, MO, USA
11 Department of Pediatrics, Washington University, St. Louis, MO, USA
*Corresponding author. Tel: +862087755766 6236; E-mail: supq@mail.sysu.edu.cn
†Present address: Department of Orthopaedic Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
‡These authors contributed equally to this work
ª 2019 The Authors. Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 11: e9709 | 2019 1 of 9
Published online: February 18, 2019 
serve as multifunctional binding sites for GAB1, GRB2, PI3K, and
other downstream substrates (Birchmeier et al, 2003). The HGF-
MET signal plays a vital role in regulating the development of skele-
tal muscle, placenta, and liver during embryogenesis (Birchmeier
et al, 1997; Haines et al, 2004; Ueno et al, 2013). In skeletal muscle
development, MET has been demonstrated not only to be crucial for
the migration of muscle progenitor cells into the limbs, tongue, and
diaphragm, but also to be necessary for the proliferation of
secondary myoblasts in the trunk (Maina et al, 1996).
Herein, we recruited a rare four-generation Chinese arthrogryposis
pedigree with only upper limb involvement, and we found the MET
c.A3701G (p.Y1234C; Refseq NM_000245.2) mutation to be responsi-
ble for the pathogenesis of arthrogryposis in this pedigree. MET
p.Y1234C mutation was shown to cause the dysfunction of phospho-
rylation and tyrosine kinase activity of MET in vitro. We established a
Met c.A3695G (p.Y1232C; Refseq NM_008591.2) mutant mouse
model, and the defective migration of myogenic progenitor cells and
impaired proliferation of secondary myoblasts were demonstrated to
be responsible for the disturbed muscle development.
Results
Clinical presentation of patients from a large
arthrogryposis family
A four-generation Chinese family presented with completely pene-
trant, autosomal dominant arthrogryposis characterized mainly by
camptodactyly (Fig 1A). All patients in this family had campto-
dactyly, and seven patients had camptodactyly, absent flexion
crease, and limited forearm supination (Fig 1B; Table EV1). Signs of
lower limb, and facial and spinal involvement were absent. Since
interphalangeal joints and carpal joints were both affected in seven
individuals, a diagnosis of arthrogryposis involving only the upper
limbs was made.
Subject IV:7 is a patient with unilateral camptodactyly, absent
flexion crease, and limited forearm supination. Severe pronator
quadratus aplasia of affected forearm was observed through magnetic
resonance imaging (MRI; Fig 1C). For the palmar muscles, loss of
lumbricalis and interosseous muscles of fifth finger of affected side was
found (Fig 1D and E). Subject IV:8 is a patient with severe bilateral
camptodactyly, absent flexion crease, and limited forearm supination.
MRI scan showed increased epimysial fat among muscle compart-
ments (Fig 1F), complete loss of thenar eminences, the radial lumbri-
calis, and interosseous muscles of both hands (Fig 1G and H). The
lumbricalis muscle of subject IV:8 showed varying fiber size and more
centrally located nuclei than control lumbricalis muscle from an age-
and gender-matched person without muscular dysplasia (Fig EV1A).
No bone abnormality was observed in arthrogryposis patients of this
pedigree (Fig EV1B). Overall, a diagnosis of arthrogryposis involving
only the upper limbs was made, and muscular dysplasia was observed
in the affected forearms and hands of these patients.
Whole-exome sequencing identified MET as a disease-causing
gene of arthrogryposis
To identify arthrogryposis-predisposing variants, whole-exome
sequencing was initially performed on four affected individuals
and one healthy member of this arthrogryposis pedigree
(Appendix Table S1). As previously reported (Gao et al, 2017), we
annotated and filtered variants, and kept variants that were novel in
dbSNP. Polyphen-2, Mutation Taster, and Genomic Evolutionary
Rate Profiling (GERP) were then used to predict the potential func-
tional effects of these mutations, which yielded two candidate SNVs,
c.A3701G in the MET; c.G2074A (Refseq NM_006019) in TCIRG1
(MIM:604592). By using Sanger sequencing, we excluded the SNV
on TCIRG1 because MET c.A3701G turned out to be the only one
which co-segregated with disease phenotypes in this family (Fig 1I,
Appendix Table S2).
MET p.Y1234C mutation caused dysfunction of the
phosphorylation and tyrosine kinase activity of MET
The influence of p.Y1234C mutation on the function of MET was
studied (Fig EV2A), and HGF treatment was shown to be unable to
phosphorylate the Y-1234/1235, Y-1349, and Y-1356 sites of mutant
MET receptor (Fig EV2B–D), suggesting MET mutation impaired the
activation of MET receptor. Moreover, the tyrosine kinase activity of
mutant MET was shown to decrease dramatically (Fig 1J).
Met mutation resulted in the reduction of limb myofibers in
transgenic mouse model
To determine the mechanism by which MET mutation causes
arthrogryposis, a Met p.Y1232C (which was identical to p.Y1234C in
human beings) mutant mouse model was constructed. No homozy-
gous newborns were found. The ratio of homozygous embryos
started to decline since E14.5, and E16.5 was the latest time that
homozygous embryos could survive, which was consistent with Met
null mutants (Schmidt et al, 1995). The failure of placental develop-
ment in homozygotes might be responsible for the death of embryos
in utero (Ueno et al, 2013).
Heterozygotes were smaller than wild-type individuals at birth
(Fig 2A and B). Compared with wild-type newborns, the mean
number of myofibers of paraspinal muscles, forelimbs, hindlimbs,
and hands of heterozygotes reduced by 14, 55, 29, and 93%, respec-
tively, while the foot muscles remained normal (Fig 2C–H). To fig-
ure out whether the myofibrils were affected, the gastrocnemius of
wild-type and heterozygous newborns was tested with transmission
electron microscope (TEM). However, no abnormality of the struc-
ture of myofibrils was found (Fig 2I).
Met mutation affected the migration of muscle progenitor cells
To determine how Met mutation affected muscle development, its
effect on muscle progenitor cells’ migrating out of dermomyotome
was examined firstly. Using in situ hybridization, expression of
Pax3 (MIM: 606597) and Met was assessed in embryonic limbs and
dermomyotome at the end of migration (E10.5). In dermomyotome,
heterozygous and homozygous embryos showed more Pax3-positive
(Pax3+) and Met-positive (Met+) cells than wild types (Figs 3A and
EV3). Pax3+ and Met+ cells were absent from homozygous limbs,
while the number of Pax3+ and Met+ cells was markedly lower in
heterozygous limbs, suggesting Met mutation impaired muscle
progenitor cells’ migration out of dermomyotome to the limb
(Figs 3A and EV3).
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Figure 1. MET p.Y1234C mutation caused arthrogryposis in a four-generation Chinese family.
A The MET p.Y1234C mutation segregated with disease phenotypes in the arthrogryposis family. Filled symbols denote affected individuals, open symbols indicate
unaffected individuals, and symbols with slashes represent decreased individuals. Asterisks indicate a mutation is present, # means wild-type.
B Phenotypes of affected individuals. Camptodactyly, absent flexion crease, and limited forearm supination were observed.
C–E T1-weighted MRI scan on upper limbs of subject IV:7. (C) The pronator quadratus absence of affected side was indicated by a red arrow. (D) No difference was
found in palmar muscles. (E) Loss of lumbricalis and interosseous muscles of fifth finger of affected side was indicated by a red arrow.
F–H T1-weighted MRI scan on upper limbs of subject IV:8. (F) Increased epimysial fat was indicated by a red arrow. (G) Completely loss of thenar eminences of both
hands was indicated by red arrows. (H) Loss of radial lumbricalis and interosseous muscles of both hands was indicated by red arrows.
I The MET variants by Sanger sequencing were indicated by a red arrow.
J 293T cells were transfected with FLAG-tagged MET/METMut/Vector plasmids, and 48 h post-transfection, cells were treated with 10 ng/ml recombinant human HGF
for 1 h. Then, MET/METMut protein purification and tyrosine kinase assay were conducted. Western blot pictures representative of n = 3 experiments. METMut
means p.Y1234C mutant MET. EGFR means epidermal growth factor receptor and serves as a positive control. NC means negative control.
Source data are available online for this figure.
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Met mutation had no effect on primary myogenesis of embryonic
muscle development
The decreased number of muscle fibers in axial muscles of P0
heterozygotes suggested that Met mutation might also affect the
myoblasts which do not undergo migration. The body size and
weight of E14.5 (the very end of primary myogenesis) homozygous
embryos were lower than that of wild types (Figs 3B and EV4A).
For muscles that derive from migratory precursors, remarkable





Figure 2. Met mutation caused the reduction of both appendicular and paraspinal muscles of P0 heterozygotes.
A Gross appearance of wild-type and heterozygous newborns.
B Graph showing weight of P0 mice. Bars show mean  SD. Sample size: WT (n = 4) and Hetero (n = 5). *P < 0.05, by one-way ANOVA and followed by Dunnett’s
post hoc test.
C–G Sections of spine, forelimbs, hindlimbs, hand, and foot from wild types and heterozygotes at P0 were conducted with HE staining and immunofluorescence
staining using anti-myosin heavy chain antibody. Scale bars, 100 lm.
H The mean number of myofibers in the muscles of the spine, forelimb, hindlimb, hand, and foot was qualified. Bars show mean  SD. NS means no statistic
significance. *P < 0.05, **P < 0.01, by two-tailed independent Student’s t-test.
I Transmission electron microscope analysis of gastrocnemius from wild-type and heterozygous newborns. Black arrows denote mitochondria. Scale bars, 2 lm. WT
means wild types, Hetero means heterozygotes.
Data information: In (C–H), n = 3.
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homozygotes showed a complete loss of muscle fibers in these areas
(limbs, front tongue, and diaphragm, Figs 3C and EV4B). For
muscles that do not originate from the migratory precursors, no
obvious difference was observed among three genotypes at E14.5
(paraspinal muscle and intercostal muscle, Figs 3C and EV4B). To
evaluate the proliferation and apoptosis of primary myoblasts, Ki67
staining and TUNEL assay were conducted in paraspinal muscle,
and no significant difference was found among all three genotypes
(Fig EV4C–F), suggesting that Met mutation had no effect on
primary myogenesis.
Met mutation suppressed proliferation of myoblasts during
secondary myogenesis
To reveal the effect of Met mutation on secondary myogenesis,





Figure 3. Met mutation led to the defects in the migration of muscle progenitor cells and impaired proliferation of secondary myoblasts.
A In situ hybridization of E10.5 embryos using Pax3 probe. Pax3 expression (brown signal) was observed in limb bud and dermomyotome (DM), respectively. Cells
labeled with Pax3 were indicated by a red arrow. Scale bars, 200 lm.
B Gross appearance of E14.5 embryos of indicated genotype. Scale bars, 2.5 mm.
C HE staining of forelimb, hindlimb, and paraspinal muscle of E14.5 embryos. Scale bars, 100 lm.
D Gross appearance of E16.5 embryos of indicated genotype. Scale bars, 2.5 mm.
E HE staining of forelimb, hindlimb, and paraspinal muscle of E16.5 embryos. n = 3, scale bars, 200 lm.
F Anti-Ki67 antibody was used to label proliferative myoblasts (red fluorescence) with DAPI-labeled nuclei (blue fluorescence) in paraspinal muscle. Scale bar, 25 lm.
G Bar graph showing statistical analysis of positive rate of Ki67-labeled nuclei, n = 3 with more than 150 cells analyzed per n, **P < 0.01, by chi-square test (v2 test).
Bars show mean  SD. WT means wild types, Hetero means heterozygotes, and Homo means homozygotes.
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that homozygotes could survive and also the late stage of secondary
myogenesis) were studied. The body size and weight of E16.5
embryos decreased in heterozygotes and homozygotes (Figs 3D and
EV5A). HE staining showed that compared to wild types, the mean
myofiber numbers in heterozygotes decreased by 46% in forelimb
and 45% in hindlimb, respectively, and a complete absence of
myofiber was observed in homozygous limbs (Figs 3E and EV5B).
HE staining revealed a graded reduction in paraspinal muscle fibers,
progressively more severe in homozygotes than in heterozygotes
(Figs 3E and EV5B).
To make it clear whether Met mutation affected apoptosis or
proliferation of secondary myoblasts, TUNEL assay and Ki67 stain-
ing were performed in paraspinal muscle of E16.5 embryos. No
significant difference in the TUNEL-positive rate was found among
all three genotypes (Fig EV5C and D). However, in heterozygous
and homozygous embryos, there was a reduction in Ki67-positive
rate of 58 and 81%, respectively, relative to wild types (Fig 3F and
G), indicating that a defect in proliferation of myoblasts was the
reason for the impaired secondary myogenesis.
Discussion
In the present study, MET p.Y1234C mutation was found to cause
arthrogryposis in a four-generation pedigree. In vitro study showed
that MET p.Y1234C mutation resulted in the failure of phosphoryla-
tion and loss of tyrosine kinase activity of MET receptor. A Met
p.Y1232C transgenic mouse model was established, and defective
migration of muscle progenitor cells and impaired proliferation of
secondary myoblasts were detected, which was in accordance with
previous study (Maina et al, 1996).
In our study, heterozygous Met p.Y1232C mutant mice also
showed reduction of myofibers’ number in both appendicular and
axial muscles. Given that various heterozygous Met loss-of-function
mutant mice did not show any abnormal phenotype (Maina et al,
1996, 2001; Sachs et al, 2000), the phenotype of Met p.Y1232C
heterozygotes is likely to be caused by a dominant negative effect
rather than by haploinsufficiency. Since Y-1232 is a crucial phosphory-
lation site in the MET kinase domain and MET activation depends on
receptor dimerization in response to ligand binding (Trusolino et al,
2010), the p.Y1232C mutant might form non-functional dimers with
the wild-type MET protein, resulting in impaired HGF-MET signaling.
A similar effect has been previously described with a kinase-domain-
truncated mutant MET (Furge et al, 2001; Long et al, 2003).
In P0 heterozygous mice, there was a complete absence of the
intrinsic muscles of the hand, while the intrinsic muscles of the foot
stayed normal, which was in accordance with the phenotypes of our
arthrogryposis patients. Meanwhile, the reduction of myofibers in
forelimb was more severe than that in hindlimb. One possible expla-
nation for this inconsistency is that MET plays a predominant role in
the early period of embryonic muscle development. As reported,
MET was indispensable to the delamination of muscle progenitor
cells from dermomyotome at the very beginning of migration. In
Met/ mice, the muscle progenitor cells failed to delaminate from
the dermomyotome, and all the muscles that derived from migration
failed to form as a result (Schmidt et al, 1995). Other genes, such as
Lbx1 and Pax3, are more important in regulating the migration of
muscle precursor cells into the limbs during later periods of
migration (Relaix et al, 2004; Masselink et al, 2017). In homozygous
Lbx1 null mutant mice, limb muscle precursor cells could delami-
nate from dermomyotome normally but failed to migrate into the
limb, which led to the loss of appendicular muscles (Gross et al,
2000). Since forelimb buds (E9.0–E9.5) formed earlier than hindlimb
buds (E9.5–E10) during embryonic muscle development, it can be
inferred that Met mutation caused severer phenotypes in forelimbs
than hindlimbs because it mainly affects the early stage of migration.
Although the reduction of myofibers in the extensor side of forelimbs
was severer than that in the flexor side in some Met mutant mice
models constructed before (Maina et al, 1996; Sachs et al, 2000), we
did not find such differences in Met p.Y1232C mutant mice. It is also
noteworthy that although Met p.Y1232C mutant mice recapitulated
the phenotypes of muscular dysplasia in arthrogryposis patients,
neither heterozygous nor homozygous mice showed contracture of
distal joint. In the arthrogryposis family we examined, all patients
with MET p.Y1234C mutation had camptodactyly, which was caused
by the loss of the intrinsic muscles of the hands. Similar to these
patients, Met c.A3695G mutant mice also showed loss of intrinsic
muscles of the hands. The reason why mutant mice had no campto-
dactyly may be that the digits of mice are relatively short, so contrac-
ture is not readily visible. However, instead of contracture at the
digits, the whole paw flexion at the wrist was observed in Met
p.Y1356F mutant homozygotes (Maina et al, 1996).
It has been reported that SNVs in the MET gene, causing lowered
MET expression, increase susceptibility to autistic spectrum disor-
ders (ASD) in European and North American populations (Campbell
et al, 2006). Mental evaluation by a psychiatrist of our arthrogrypo-
sis patients revealed no sign of ASD, possibly owing to the dif-
ference in genetic background among populations.
To the best of our knowledge, this is the first study to report
MET as a causative gene of arthrogryposis. Though several mouse
models have been established to study the role of MET on the devel-
opment of skeletal muscle, the present study is the first to demon-
strate a direct relationship between MET mutation and skeletal
muscle dysplasia in arthrogryposis patients.
Materials and Methods
Subjects
Patients were recruited and evaluated in the First Affiliated Hospital
of Sun Yat-sen University. Patients provided a detailed medical
history, received physical examinations and mental evaluation, and
underwent standard posterior–anterior plain X-rays of both the
hands and the feet. MRI, electromyogram, and blood biochemical
examination were conducted in subject IV:7. Histological analysis of
lumbricalis and MRI were conducted in subject IV:8, and the lumbri-
cales of an age- and gender-matched person with a severe hand
injury served as normal control.
Genetic studies
Exome sequences were enriched with an Agilent SureSelect Human
All Exon V5 Kit (Agilent Technologies). Sequences were generated
on a HiSeq PE150 (Illumina). Base calling was performed, and raw
sequencing read files were generated in FASTQ format.
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Subsequently, the sequenced reads were aligned to the reference
human genome (NCBI Build 37, hg19). SeattleSeq Annotation 150
(version 9.10) was used to perform the annotation. Various data-
bases, including dbSNP database, 1000 genomes, Mutation Taster,
Polyphen-2, and SIFT, were used to predict and filter mutations. Data
analysis was performed as given below: Exome capture was
performed using an Agilent SureSelect Human All Exon Kit and
sequences were generated on HiSeq PE150. After mapping to the
human reference genome (NCBI Build 37, hg19), an average of
99.3% of reads were mapped and a sequencing depth per target base
of 168 times on average was provided, with at least 20 times for 99%
of bases. More than 154,876 SNVs per individual were identified. We
first chose variants that were shared by the four affected individuals
but not present in the unaffected individual. We found 5,350 such
variants. Next, to identify potentially pathogenic variants, we anno-
tated those variants and filtered out synonymous variants, non-
coding variants, intergenic variants, and variants located in introns,
retaining those affecting splice sites. We then parsed a total of 1,441
variants and kept only those that were novel in dbSNP.
Immunoprecipitation
Flag-tagged MET, p.Y1234C mutant MET (METMut), and Vector plas-
mids were expressed in a 293T cell expression system. Forty-eight
hours post-transfection, cells were treated with 10 ng/ml recombi-
nant human HGF (PeproTch, Catalog No. 100-39H-25) for 1 h. As
previously reported (Lian et al, 2016; Liu et al, 2018), lysates were
prepared from 5 × 107 293T cells transfected with indicated plas-
mids using RIPA Lysis Buffer (Beyotime, Catalog No. P0013D).
Lysates were incubated with 20 ll anti-Flag affinity agarose (Sigma-
Aldrich, Catalog No. A4596) overnight at 4°C. Beads containing
affinity-bound proteins were washed seven times with 5 ml wash
buffer (300 mM NaCl, 20 mM HEPES, 1 mM EDTA, 1 mM EGTA,
2% glycerol, pH 7.4, and 0.1% NP-40) and collected by centrifuga-
tion. Samples were subjected to SDS–PAGE and immunoblotting
analysis after the addition of 30 ll of sample buffer [62 mM
Tris–HCl, 1.25% (w/v) SDS, 10% (v/v) glycerol, 3.75% (v/v)
mercaptoethanol, and 0.05% (w/v) bromophenol blue, pH 6.7] and
denaturation. The following antibodies were used: 1:1,000 dilution of
anti-Phospho-Met (Tyr1234/1235) antibody (CST, Catalog No. #3077),
1:1,000 dilution of anti-Phospho-Met (Tyr1349) antibody (Abcam,
Catalog No. ab68141), 1:500 dilution of anti-Phospho-Met (Tyr1356)
antibody (Abcam, Catalog No. ab73992), 1:2,000 dilution of anti-
GAPDH antibody (Proteintech, Catalog No. 60004-1-lg), and 1:1,000
dilution of anti-FLAG antibody (Sigma-Aldrich, Catalog No. F1804).
Tyrosine kinase assay
Flag-tagged MET/METMut/Vector plasmids were expressed in a 293T
cell expression system. Forty-eight hours post-transfection, cells were
treated with 10 ng/ml recombinant human HGF for 1 h. MET/METMut
protein purification and tyrosine kinase assay were conducted accord-
ing to the operations manual (Sigma-Aldrich, Catalog No. CS0730).
Generation of CRISP/Cas9 Met mutant mice
The mouse Met gene (GenBank accession number: NM_008591.2;
Ensembl: ENSMUSG00000009376) is located on mouse chromosome
6, and human MET c. A3701G is identical to Met c.A3695G in mouse
gene. Twenty-two exons have been identified, with the ATG start
codon in exon 3 and TGA stop codon in exon 22. The Tyr1232 is
located on exon 20. Exon 20 was selected as a target site. MET
gRNA targeting sequencing 50-GCTTGGCACCCGTCTTGTTGTGG-30
and donor oligo were designed. The Tyr1232Cys (TAC to TGC)
mutation sites in donor oligo were introduced into exon 20
using homology-directed repair. A silent mutation (GTC to GTA
or ACG to ACT) was also introduced to prevent the binding and
recutting of the sequence by gRNA after homology-directed
repair. Cas9 mRNA, gRNA generated by in vitro transcription,
and donor oligo were co-injected into fertilized eggs for KI
mouse production.
Histological study
Tissues from E14.5, E16.5, and P0 mice were dissected and fixed in
4% paraformaldehyde overnight, dehydrated, and embedded in
paraffin. Sections for histological analysis were rehydrated and
stained with hematoxylin-eosin. Immunofluorescence was
performed with Histostain-Plus Kit (ZSGB-BIO, Catalog No. SPN-
9002). Primary antibodies included: 1:400 dilution of anti-myosin
antibody (Sigma, Catalog No. M4276); 1:200 dilution of anti-Ki67
antibody (Abcam, Catalog No. ab16667). Detection was conducted
using 1:1,000 dilution of anti-mouse IgG fragment, Alexa Fluor 555
conjugate (CST, Catalog No. #4409), and 1:1,000 dilution of anti-
rabbit fragment, Alexa Fluor 555 conjugate (CST, Catalog No.
#4413S). Nucleus was stained by DAPI in a final concentration of
0.1 lg/ml (CST, Catalog No. #4083). TUNEL assay was performed
according to the manufacturer’s instructions (MBL, Catalog No.
8445). Quantification of Ki67-positive rate and TUNEL-positive rate
was conducted using ImageJ (version 1.51) software.
Transmission electron microscopy
Transmission electron microscope analysis was performed on the
gastrocnemius in standard fashion. Ultra-thin sections were
stained with uranyl acetate and lead citrate, and then examined
using a Tecnai transmission electron microscope (FEI) operated at
80 kV.
Mouse embryos in situ hybridization
In situ hybridization using RNAscope probes was performed on
E10.5 mouse embryos. Embryos were fixed with 4% paraformalde-
hyde for 24 h at 4°C, dehydrated, and embedded in paraffin.
Tissue sections were washed twice with PBS for 5 min, followed
by incubation in hydrogen peroxide (ACD, Catalog No. 322335)
for 10 min at room temperature, boiling in target retrieval (ACD,
Catalog No. 322000) for 15 min. After target retrieval, slides were
briefly washed with distilled water and incubated for 30 min at
40°C with Protease Plus (ACD, Catalog No. 322331). Following all
pretreatments, the manufacturer’s protocol for RNAscope 2.5 HD
Detection Kit-Brown (ACD, Catalog No. 322310) was followed to
hybridize probes and detect the signals. The following probes were
used: RNAscope Probe-Mm-Pax3 (ACD, Catalog No. 455801);
RNAscope Probe-Mm-Met (ACD, Catalog No. 405301); RNAscope
Negative Control Probe-DapB (ACD, Catalog No. 310043); and
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RNAscope Positive Control Probe-Mm-Ppib (ACD, Catalog No.
313911).
Statistical analysis
All quantitative data are here presented as mean  standard devia-
tion (SD). Statistical analysis of body weight of transgenic mice was
performed using one-way ANOVA followed by Dunnett’s post hoc
test for multiple comparisons. The positive rates of Ki67- and
TUNEL-labeled cells were analyzed using the chi-square test (v2
test). All statistical analyses were conducted with the SPSS (version
19.0) statistical software. The level of statistical significance was set
at P < 0.05. See Appendix Statistical Analysis for the exact P-value
in each experiment.
Study approval
Written informed consent was obtained from all subjects or, in the
case of children under 16 years of age, their parents. Collection and
usage of patient samples for this study were approved by the Ethics
Committee of the First Affiliated Hospital of Sun Yat-sen University.
All procedures in studies involving human participants were
performed in accordance with the principles set out in the WMA
Declaration of Helsinki and the Department of Health and Human
Services Belmont Report. Transgenic mice were raised in the labora-
tory animal center of Sun Yat-sen University, and all animal experi-
ments, housing, and husbandry followed the operating procedures
approved by the Institutional Animal Care and Use Committee of
Sun Yat-sen University.
Data availability
The whole-exome sequencing data of arthrogryposis patients are
available in the Clinvar dataset (https://www.ncbi.nlm.nih.gov/clin
var/), and accession ID is SCV000606865.
Expanded View for this article is available online.
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